Print Page   |   Sign In   |   Register
Press Releases
Share |

   This year there are a record number of physicians running for seats in the Maryland Statehouse.* This is an unprecedented opportunity for medicine to increase its representation in Annapolis, and for MSEPS to forge new relationships with our legislators.

   Each of the physicians listed below had an opportunity to address the MSEPS membership at a lunch symposium during our Annual Meeting May 2.  We urge you to visit their websites and consider supporting them.



David Glasser, M.D., MSEPS President, led a group of young ophthalmologists in training to meet with legislators and their aides to advocate for issues important to ophthalmologists and their patients, including availability of affordable drugs, improving electronic health records, empowering patiens in choosing healthcare providers and funding of research into eye diseases.  This Advocacy Day effort was a part of the American Academy of Ophthalmology's Mid-Year Forum held April 10-12 in Washington, D.C.



Pictured, left to right: Nora Khatib, M.D. (Ophthalmology Resident at University of Maryland), Alvin Liu, M.D. (Ophthalmology Resident at Johns Hopkins University), Roni Levin, M.D. (Pediatric Fellow at Johns Hopkins University), David Glasser, M.D. (MSEPS President) and Basil Morgan, M.D. (MSEPS Past President).

February  2013

Maryland Physician Advisory:   

Be Warned Over the Use of Illegally Imported Prescription Drugs


The US Food and Drug Administration is cracking down on physicians who are buying illegally imported drugs and selling them in the United States.  

Illegal prescription drug importation occurs when foreign pharmacies, traders or suppliers ship pharmaceuticals not intended for sale in the United States (and which may or may not have been approved for use in foreign countries) into the United States for use by American consumers.  The importation and counterfeiting of prescription drugs is a growing problem.  In 2000, FDA opened 6 counterfeit drug investigations; in 2004, FDA opened 58. 

In December 2012, the FDA issued letters to over 350 medical practices that they may have received unapproved medications from a foreign supplier that may be counterfeit, contaminated, improperly stored and transported, ineffective and/or unsafe.[1]  FDA warned these medical practices to stop purchasing and administering drugs received from foreign or unlicensed suppliers because they were placing patients at risk and violating federal law.  FDA also posted a list of all of the doctors that received the letter.[2]

Some physicians see importation as a cost-saving alternative because some prescription drugs are sold at lower prices in foreign countries due to artificial price controls in those other countries and because the foreign and unlicensed importers do not comply with FDA regulations.  These healthcare practitioners can undercut competitors selling legitimate drugs.  More importantly, the patients who visit these practitioners usually do not realize they are being treated with illegally-imported drugs, nor do they understand the risks associated with such treatment.  

Indeed, the importation of prescription drugs not only is illegal; it also poses significant health risks to consumers.  Imported drugs are often counterfeit, do not contain the same active ingredients, and do not contain the same important instructions and warnings as their U.S. counterparts and/or may be compromised in some way (e.g., due to inadequate storage or shipping). 

For more information, you can read this recent Wall Street Journal article:

If you believe you have been sold, or solicited to purchase, illegally imported drugs, you can report this suspected criminal activity to FDA’s Office of Criminal Investigations (OCI) by calling 1-800-551-3989 or visiting the OCI website:







Community Search
Sign In







Take Advantage of the Third Party Insurance Help Program 

Have a coding question? Use the new MSEPS member benefit!

Copyright © 2014 Maryland Society of Eye Physicians & Surgeons

MSEPS / 1211 Cathedral Street / Baltimore, MD 21201 / 410-244-7320